Complete Up To Date Information about Capstar .
NADA Number: 141-175 | |
| Proprietary Name |
Capstar® |
|---|---|
| Sponsor |
Novartis Animal Health US, Inc. |
| Sponsor Address |
3200 Northline Ave, Suite 300 Greensboro, NC 27408 USA |
| Ingredients |
Nitenpyram |
| Species |
Dog, excluding under 2 pounds Cat and kitten, excluding under 4 weeks of age Dog and puppy, excluding under 4 weeks age Cat and kitten, excluding under 2 pounds weight |
| Routes of Administration |
Per Os |
| Dose Form |
Tablet |
| Drug Form |
Tablet |
| Dispensing Status |
OTC |
| Patent Number |
5750548 |
| Exclusivity |
No product using nitenpyram (including any ester or salt of the drug) as an active ingredient has been previously approved for use in horses in any other application. Granted for the concurrent use with NADA 141-035 and NADA 141-084. |
|
Dosage Amount, Indications & Limitations |
520.1510 Nitenpyram. Specifications. Each tablet contains 11.4 or 57 milligrams of nitenpyram. Conditions of use: Dogs and cats Amount: One tablet given orally, as needed. Indications: For the treatment of flea infestations. The concurrent use of flavored lufenuron tablets with nitenpyram tablets is indicated to kill adult fleas and prevent flea eggs from hatching. Limitations: For use in dogs, puppies, cats, and kittens 4 weeks of age and older and 2 pounds of body weight or greater. |